Until then, the methodology remains the most robust, defensible, and patient-safe approach available today. Conclusion: Don’t Just Repack—Validate, Verify, and Protect The phrase “Nuria Millan testing repack” has become shorthand in compounding circles for uncompromising quality. It reminds us that repackaging is not a clerical task—it is an aseptic manufacturing process that demands the same rigor as a pharmaceutical factory.
Whether you are a hospital pharmacist, a lab manager, or a regulatory inspector, adopting Millan’s principles means choosing active prevention over reactive correction. Test not just to pass an inspection, but because every syringe, vial, or bag you repackage will eventually enter a patient’s bloodstream. nuria millan testing repack
Millan’s philosophy is simple but profound: “Testing without understanding the process is just a snapshot. A repack testing protocol must be dynamic, risk-based, and continuous.” Most compounding facilities rely on periodic, batch-based testing. They repackage a batch of syringes, send a few samples to a lab, and assume the entire batch is safe if those samples pass. Nuria Millan challenges this approach. She argues that end-point testing is necessary but insufficient. Until then, the methodology remains the most robust,